nmsg

Nerviano Medical Sciences to present data on novel molecules suitable for the generation of novel antibody drug conjugates at the AACR Annual Meeting 2014

Nerviano, Feb 25, 2014. – Nerviano Medical Sciences will disclose data on novel molecules suitable for the generation of novel antibody drug conjugates at the AACR Annual Meeting 2014.

Thienoindoles, a novel class of DNA minor groove alkylating agents highly suited for the generation of novel antibody drug conjugates (ADCs). Valsasina, B et al.

Abstract number: 822/9. Presentation time: Sun, Apr 06, 1:00 - 5:00 PM

Further details will be disclosed when abstract bodies will be made available on the conference website, at the following link .

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 
To give you a better browsing experience, NMS Group and Group Companies use own and third part cookies.
Browsing this web site, you allow to use them, according to our  
Cookie Policy.